Kissing, caressing, hugging and even receiving sweet and pleasant words trigger
oxytocin
, a neurohormone that, when released, acts on different
brain areas
and causes
pleasurable sensations -through
sexual intercourse, but also through exercise or art- and promotes
social
ties
.
Its functions are also present in uterine contractions, as well as in the regulation of breastfeeding and ejaculation, sperm transport and testosterone production in men.
To those already known, it is now added that of promoting the activation of the epicardial cells and the
regeneration of the heart
after a cardiac injury;
that is, it appears as a potential 'coadjuvant' that would support healing
after a heart attack
, according to a study published in the latest Frontiers in Cell and Developmental Biology, where it is shown that this discovery could be transferred to the clinic to promote the regeneration of the human heart after heart attack.
The observation is the work of researchers at Michigan State University (USA) who have shown -
in human
and
zebrafish
cell cultures - that oxytocin has another unsuspected function: it stimulates stem cells derived from the
epicardium
, the outer layer of the heart, so that they migrate to the myocardium, its middle layer, and there they
develop into cardiomyocytes
, muscle cells that generate the contractions of the heart.
Cardiovascular disease (CVD) is the leading cause of mortality in developed countries and very often leads to serious cardiac events, such as
myocardial infarction
that can cause the
death of more than 25% of cardiac myocytes
, the main contractile cells of the adult heart.
If left untreated, this condition can lead to heart failure.
Potential therapies in humans
Aitor Aguirre
, from the Division of Stem Cell and Developmental Biology and the Department of Biomedical Engineering at Michigan State University (USA) and
lead author
of the study, points out that "we show that oxytocin, a neuropeptide also known as the ' hormone of love', is capable of
activating heart repair mechanisms
in human and zebrafish cell cultures in injured hearts, opening the door to new
potential therapies
for heart regeneration in humans."
The US team hypothesizes that oxytocin
is released from the brain into the bloodstream
after cardiac injury to facilitate
epicardial activation
and regeneration of the heart.
According to their data, “Oxytocin mRNA levels were increased—up to 20-fold in zebrafish brains three days after cardiac cryoinjury—with a corresponding increase observed in wt1b expression in injured hearts.”
The oxytocin then travels to the zebrafish epicardium and binds to the oxytocin receptor, triggering a molecular cascade that stimulates local cells to expand and
become
epicardial-derived progenitor
cells ( EpiPCs
)
.
Cardiac muscle cells regenerate in zebrafish.
Photo: DM.
The new EpiPCs then migrate to the zebrafish myocardium to become
cardiomyocytes, blood vessels, and other
important cardiac cells, to replace those that were lost, results that suggest "this newly synthesized neurohormone travels to the heart to induce epicardial activation, a
phenomenon that has not been previously described"
.
After a
myocardial infarction,
cardiomyocytes usually die in large numbers.
Because they are highly specialized cells,
they cannot replenish themselves.
However, previous studies have shown that a subset of cells in the epicardium can be
reprogrammed to become EpiPCs
, which can
regenerate
not only cardiomyocytes, but also other cardiac cell types.
"You have to think of EpiPCs like the
masons
who repaired cathedrals in Europe in the Middle Ages. Unfortunately for us, the production of EpiPCs is
inefficient
for heart regeneration in humans under natural conditions," explains Aguirre.
'magic bullet'
The
zebrafish
has been the chosen model to study if it would be possible to regenerate hearts more efficiently and how to carry it out, since it is famous for its
extraordinary capacity to regenerate organs
, including the brain, the retina, the internal organs, the bones and skin.
"They do not suffer heart attacks, but their many predators attack any of their organs, including the heart, so the zebrafish is able to
regenerate it even losing up to a quarter of it"
.
The researchers explain that this phenomenon is due, in large part, to the proliferation of cardiomyocytes, but also to EpiPCs.
But, they wonder: how do zebrafish EpiPCs repair the heart so efficiently?
Can
we find a 'magic bullet' in zebrafish
that can artificially boost EpiPC production in humans?
The answer is yes
.
And this 'magic bullet' appears to be
oxytocin
, they point out.
In the research, the team shows that oxytocin in zebrafish has a similar effect on
human tissue in vitro
and is unique.
No other of the
other fourteen neurohormones tested and analyzed
stimulates cultures of human induced pluripotent stem cells (hIPSCs) to convert to EpiPC, at up to twice the basal rate: a
much stronger effect than other molecules
previously shown to stimulate epiPC.
EpiPC production in mice.
In contrast,
genetic deletion of the oxytocin receptor
prevented regenerative activation of human EpiPCs in culture.
Analysis has also shown that the link between oxytocin and EpiPC stimulation is "the important
TGF- signaling pathway,
" known to regulate cell growth, differentiation, and migration.
In view of the data, Aguirre considers that "it is likely that oxytocin stimulation of EpiPC production is
evolutionarily conserved in humans
to a significant degree.
It's not an illusion
Oxytocin is widely used in the clinic for other reasons, so reuse for patients
after heart damage is not wishful thinking
.
Even if heart regeneration were only partial, the benefits to patients could be significant."
The next step will be to analyze the status of oxytocin in humans after cardiac injury.
Research shows that oxytocin itself is
short-lived in the circulation
, so its effects on patients could be hampered by this fact.
"
Specifically designed drugs
- with a longer half-life or greater potency - could be useful in this context. Both experimental
preclinical trials and clinical trials
in patients must continue to advance in this field," concludes Aguirre.
Conforms to The Trust Project criteria
Know more
Cardiology
Hope Aguirre
Add
Europe